FIELD: biotechnology.
SUBSTANCE: compound of formula Ala-Trp-Lys-Val-Leu-Ser-Pro-Gln-Gly-Gly is represented, and can be used to create a drug for Alzheimer's disease treatment.
EFFECT: therapeutic action against Alzheimer's disease.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE HAVING CURATIVE EFFECT AGAINST ALZHEIMER DISEASE | 2014 |
|
RU2558242C1 |
PEPTIDE HAVING THERAPEUTIC EFFECT AGAINST ALZHEIMER'S DISEASE | 2018 |
|
RU2677296C2 |
PEPTIDE WITH PROTECTIVE ACTION AGAINST ALZHEIMER'S DISEASE | 2008 |
|
RU2372355C1 |
PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES HAVING EFFECT ON SURVIVIN IN TUMOUR TISSUE | 2009 |
|
RU2396277C1 |
PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST OLIGOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401275C1 |
PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST MONOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401274C1 |
GLP-1 ANALOGUE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND THEREOF APPLICATION | 2010 |
|
RU2565536C2 |
GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
SITE-SPECIFIC MONOPHYLATED ANALYGES OF EXCENDIN AND THE METHOD OF THEIR PRODUCTION | 2012 |
|
RU2625015C2 |
METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
Authors
Dates
2017-08-02—Published
2016-03-11—Filed